Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain - Colomer, R; Llombart-Cussac, A; Tusquets, I (Clin Transl Oncol, 2006)
et al.